The go-to-market strategy is now implemented following the split with Thermo Fisher during the quarter. Q-linea will focus on Italy, Benelux and the UK (together with the distribution partner Pro-Lab Diagnostics) in Europe whilst initially targeting the US market from Boston. This is combined with recruiting e new CFO and doubling the convertible credit facility from Nexttobe from SEK 100m to SEK 200m. This is positive and, at the same time, still challenging. The ability to build on the early positive traction in Italy and the market activity in the UK is probably a good near-term indication of the progress ahead.
LÄS MER